CMPICheckmate Pharmaceuticals Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$231.4M
Vol63,651.00
50

Neutral Sentiment

How do you feel about CMPI?

About

Checkmate Pharma is a clinical-stage biopharmaceutical company developing a new approach for cancer immunotherapy. The clinical programs are focused on enabling more people with cancer to benefit from the promise of novel immunotherapies. They leveraging their expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies and to provide new treatment options for patients and their healthcare providers. Checkmate Pharmaceutical was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Checkmate Pharmaceuticals Inc?
What is the 52-week high for Checkmate Pharmaceuticals Inc?
What is the 52-week low for Checkmate Pharmaceuticals Inc?
What is Checkmate Pharmaceuticals Inc stock price today?
What was Checkmate Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Checkmate Pharmaceuticals Inc?
What is the Price-to-Book ratio of Checkmate Pharmaceuticals Inc?
What is the 50-day moving average of Checkmate Pharmaceuticals Inc?

Latest CMPI News

View
Top Discussions

Advertisement|Remove ads.